Ikema Shunsuke, Miura Gen, Shimizu Daisuke, Baba Takayuki
Department of Ophthalmology and Visual Science Chiba University Graduate School of Medicine Chiba Japan.
Clin Case Rep. 2023 Nov 14;11(11):e8181. doi: 10.1002/ccr3.8181. eCollection 2023 Nov.
This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID-19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.
本报告介绍了一名健康男性患者在接种新冠疫苗后发生急性黄斑神经视网膜病变的临床 findings 和预后情况。异常 findings 在发病后约 1 个月有所改善,并在 3 个月后消失。主观症状在 3 个月内消失,且 1 年内未观察到复发。